Cornelia D Cudrici
National Heart, Lung, and Blood Institute (NHLBI)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Cornelia D Cudrici as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:16 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06923072 · Baricitinib in the Treatment of Kohlmeier-Degos Disease in Patients With Neurological InvolvementNational Heart, Lung, and Blood Institute (NHLBI) · recruiting · Kohlmeier-Degos Disease, Malignant Atrophic Papulosis, Degos Disease · principal investigator
- Ph1/Ph2NCT05998395 · JAK/STAT Inhibition in CNS Kohlmeier-Degos DiseaseNational Heart, Lung, and Blood Institute (NHLBI) · completed · Kohlmeier Degos Disease With Neurologic Involvement, Kohlmeier-Degos Disease · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:16 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 08:16 UTC. The ranking covers the 200 most relevant of 2 PubMed records, and a shared surname and initials can bring in a namesake. All 2 on PubMed